Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.00026169541091064665,40.87128712871287,337.1198345095362,"['COX8A', 'GSTP1', 'COX5A']",0.07562997375317689,0,0,3
2,Cytoplasmic Ribosomal Proteins WP477,0.0011649433151432757,4.171441261381301,28.178431323194395,"['RPS16', 'RPL27A', 'RPLP0', 'RPS6', 'RPL36', 'RPL14', 'RPL23A', 'RPS11']",0.14258909304884285,0,0,8
3,Computational Model of Aerobic Glycolysis WP4629,0.001973551460883638,15.322091584158416,95.42476961675939,"['LDHA', 'PKM', 'GAPDH']",0.14258909304884285,0,0,3
4,Glycolysis in senescence WP5049,0.001973551460883638,15.322091584158416,95.42476961675939,"['LDHA', 'PKM', 'GAPDH']",0.14258909304884285,0,0,3
5,Metabolic reprogramming in colon cancer WP4290,0.0028861766029292047,5.693407960199005,33.29403989739129,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'GAPDH']",0.15897977650049766,0,0,5
6,Cori Cycle WP1946,0.003300618197242166,12.256188118811881,70.02751403774404,"['LDHA', 'PGAM1', 'GAPDH']",0.15897977650049766,0,0,3
7,Cholesterol Biosynthesis Pathway WP197,0.005066914817299238,10.212252475247524,53.971990887266244,"['HMGCS1', 'CYP51A1', 'MSMO1']",0.20919119745706855,0,0,3
8,Selenium Micronutrient Network WP15,0.006696487779411262,3.846087905236908,19.2541779732695,"['SERPINA3', 'SELENOS', 'PRDX1', 'HBA1', 'SELENOK', 'ICAM1']",0.24191062103123184,0,0,6
9,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.011185797504251426,16.30617283950617,73.26543453053647,"['CYP51A1', 'DHCR24']",0.35918838652540697,0,0,2
10,Glycolysis and Gluconeogenesis WP534,0.01276787888286004,4.81126842796672,20.981088693438366,"['LDHA', 'PKM', 'PGAM1', 'GAPDH']",0.3689916997146551,0,0,4
11,HIF1A and PPARG regulation of glycolysis WP2456,0.014678792397276505,13.587654320987655,57.35826523398101,"['LDHA', 'GAPDH']",0.3856519093466282,0,0,2
12,Cytosine methylation WP3585,0.018575202359721953,11.645855379188713,46.419538643607396,"['TDG', 'TET3']",0.4304334395967108,0,0,2
13,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.019362057836530246,2.9985402347789063,11.827561772522976,"['COX8A', 'NDUFB9', 'NDUFS3', 'SLC25A4', 'COX5A', 'ATP5F1D']",0.4304334395967108,0,0,6
14,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.02099453275051312,4.088089330024814,15.794305410809926,"['HMGCS1', 'CYP51A1', 'MSMO1', 'DHCR24']",0.43338714034987796,0,0,4
15,Type II interferon signaling (IFNG) WP619,0.02634508471585887,5.102413366336633,18.554791297306167,"['SOCS3', 'HLA-B', 'ICAM1']",0.49397031979679784,0,0,3
16,Folate Metabolism WP176,0.027938697179193887,3.7155425219941347,13.29325459761454,"['SERPINA3', 'AHCY', 'HBA1', 'ICAM1']",0.49397031979679784,0,0,4
17,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.03177774633292983,4.709348819497334,16.242492440540957,"['BAD', 'KRAS', 'FOXO4']",0.49397031979679784,0,0,3
18,Mitochondrial complex I assembly model OXPHOS system WP4324,0.031865496108964365,3.553565648937318,12.24640981005585,"['NDUFB9', 'NDUFAF4', 'NDUFS3', 'NDUFAF3']",0.49397031979679784,0,0,4
19,RalA downstream regulated genes WP2290,0.0324755573568829,8.150617283950618,27.934346161770062,"['RAC3', 'KRAS']",0.49397031979679784,0,0,2
20,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.04759216135978001,2.655230341797506,8.085407949750234,"['POMC', 'CREB3', 'BAD', 'RPS6', 'ZNF516']",0.6782524066742431,0,0,5
21,Mitochondrial complex III assembly WP4921,0.049284776955567836,6.268566001899336,18.869261449753132,"['UQCC3', 'CYC1']",0.6782524066742431,0,0,2
22,IL-5 signaling pathway WP127,0.0587912519334544,3.599519510774607,10.200182370226099,"['SPRED1', 'RPS6', 'KRAS']",0.7528575489944465,0,0,3
23,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06159313315567626,1.5989148249973564,4.456503217969894,"['RPS6', 'CLTC', 'FOXO4', 'ICAM1', 'LDHA', 'ADAMTS1', 'DNAJB9', 'PTPN9', 'CCT7', 'ATP6V0D1', 'RPS11', 'PTMA', 'GAPDH', 'SLC25A25', 'ARF6']",0.7528575489944465,0,0,15
24,Vitamin B12 metabolism WP1533,0.0627361168135344,3.4964639321074964,9.681072171739682,"['SERPINA3', 'HBA1', 'ICAM1']",0.7528575489944465,0,0,3
25,Nanomaterial induced apoptosis WP2507,0.06852614067621284,5.092283950617284,13.650070774136488,"['ENDOG', 'DIABLO']",0.7528575489944465,0,0,2
26,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.07112911786250832,2.6772973192856853,7.076788875019214,"['ACLY', 'HMGCS1', 'CYP51A1', 'DBI']",0.7528575489944465,0,0,4
27,IL-6 signaling pathway WP364,0.07527839116327793,3.2198410630536736,8.328319039785955,"['SOCS3', 'BAD', 'NR2F6']",0.7528575489944465,0,0,3
28,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.07540566203018143,4.792447349310095,12.387867342841858,"['LDHA', 'RPS6']",0.7528575489944465,0,0,2
29,Interleukin-11 Signaling Pathway WP2332,0.08420512724836687,3.058477722772277,7.568201491472351,"['SOCS3', 'RPS6', 'ICAM1']",0.7528575489944465,0,0,3
30,Peptide GPCRs WP24,0.08420512724836687,3.058477722772277,7.568201491472351,"['FSHR', 'OPRL1', 'HCRTR1']",0.7528575489944465,0,0,3
31,Regulation of Microtubule Cytoskeleton WP2038,0.08420512724836687,3.058477722772277,7.568201491472351,"['SPRED1', 'PARD6A', 'CFL2']",0.7528575489944465,0,0,3
32,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.08796266495161012,2.4737198285585382,6.013224075141662,"['GADD45B', 'BAD', 'RAC3', 'KRAS']",0.7528575489944465,0,0,4
33,Ras signaling WP4223,0.09195750619548759,1.8714705882352942,4.466131118883755,"['SHC3', 'RASA4B', 'BAD', 'RAC3', 'KRAS', 'FOXO4', 'ARF6']",0.7528575489944465,0,0,7
34,Effects of nitric oxide WP1995,0.09279820967081485,13.556650246305418,32.22860329105241,['HBA1'],0.7528575489944465,0,0,1
35,Gastric acid production WP2596,0.09279820967081485,13.556650246305418,32.22860329105241,['CCK'],0.7528575489944465,0,0,1
36,Leptin signaling pathway WP2034,0.09890270385710422,2.3657352465206603,5.473409308967652,"['SOCS3', 'BAD', 'CFL2', 'RPS6']",0.7528575489944465,0,0,4
37,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.1048691318791986,3.8786596119929455,8.746540597291748,"['FSHR', 'RPS6']",0.7528575489944465,0,0,2
38,Nonalcoholic fatty liver disease WP4396,0.10749315363037835,1.9005973438496782,4.238955701929033,"['COX8A', 'SOCS3', 'NDUFB9', 'NDUFS3', 'CYC1', 'COX5A']",0.7528575489944465,0,0,6
39,Synaptic Vesicle Pathway WP2267,0.10834571152174634,2.717821782178218,6.040163585515784,"['CLTC', 'SLC17A6', 'SLC25A4']",0.7528575489944465,0,0,3
40,Acetylcholine Synthesis WP528,0.1146229248767048,10.166871921182265,22.022537033560013,['CHKA'],0.7528575489944465,0,0,1
41,Oxidative phosphorylation WP623,0.12396805431079297,2.5474938118811883,5.3184827538281425,"['NDUFB9', 'NDUFS3', 'ATP5F1D']",0.7528575489944465,0,0,3
42,7-oxo-C and 7beta-HC pathways WP5064,0.12864882845969364,3.3932098765432097,6.95834978417916,"['THEM5', 'ACOT4']",0.7528575489944465,0,0,2
43,SARS-CoV-2 mitochondrial interactions WP5038,0.12864882845969364,3.3932098765432097,6.95834978417916,"['NDUFB9', 'IRF3']",0.7528575489944465,0,0,2
44,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.135196590830007,2.0916205382706625,4.185385680851439,"['SHC3', 'BAD', 'RPS6', 'KRAS']",0.7528575489944465,0,0,4
45,Molybdenum cofactor (Moco) biosynthesis WP4507,0.13592386037352183,8.133004926108374,16.23071586579137,['MOCS2'],0.7528575489944465,0,0,1
46,Pathways in clear cell renal cell carcinoma WP4018,0.13952610952542724,2.065018688946823,4.067061597762423,"['ACLY', 'LDHA', 'PKM', 'GAPDH']",0.7528575489944465,0,0,4
47,Pancreatic adenocarcinoma pathway WP4263,0.15283860965421478,1.9891060945348908,3.7362826911687623,"['GADD45B', 'BAD', 'RAC3', 'KRAS']",0.7528575489944465,0,0,4
48,IL-18 signaling pathway WP4754,0.1561979592389705,1.556749015395632,2.8903086473288404,"['SOCS3', 'IMP3', 'BAD', 'RPS11', 'RND2', 'ICAM1', 'PTMS', 'ARF6']",0.7528575489944465,0,0,8
49,Insulin signaling in adipocytes (diabetic condition) WP3635,0.15671355528459321,6.777093596059113,12.560229020431917,['RPS6'],0.7528575489944465,0,0,1
50,Insulin signaling in adipocytes (normal condition) WP3634,0.15671355528459321,6.777093596059113,12.560229020431917,['RPS6'],0.7528575489944465,0,0,1
51,Mevalonate pathway WP3963,0.15671355528459321,6.777093596059113,12.560229020431917,['HMGCS1'],0.7528575489944465,0,0,1
52,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.15671355528459321,6.777093596059113,12.560229020431917,['VEGFB'],0.7528575489944465,0,0,1
53,Sleep regulation WP3591,0.1620125756986678,2.9077601410934744,5.292359912916909,"['AHCY', 'HCRTR1']",0.7528575489944465,0,0,2
54,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.16540881533899535,1.4893495819176856,2.6798391289234704,"['CREB3', 'LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'PELO', 'EPOR']",0.7528575489944465,0,0,9
55,Oncostatin M Signaling Pathway WP2374,0.16911343402470064,2.1825053041018387,3.878716959025352,"['SOCS3', 'RPS6', 'KRAS']",0.7528575489944465,0,0,3
56,Proteasome Degradation WP183,0.16911343402470064,2.1825053041018387,3.878716959025352,"['PSMC3', 'HLA-B', 'PSMB10']",0.7528575489944465,0,0,3
57,Heme Biosynthesis WP561,0.1770042497341067,5.808585503166784,10.058039412784682,['UROD'],0.7528575489944465,0,0,1
58,miRNA regulation of prostate cancer signaling pathways WP3981,0.1792257098346822,2.71358024691358,4.664941089434871,"['BAD', 'KRAS']",0.7528575489944465,0,0,2
59,Mitochondrial CIV Assembly WP4922,0.1792257098346822,2.71358024691358,4.664941089434871,"['COX8A', 'COX5A']",0.7528575489944465,0,0,2
60,Endometrial cancer WP4155,0.18712315216527392,2.071152877999664,3.471228014151541,"['GADD45B', 'BAD', 'KRAS']",0.7528575489944465,0,0,3
61,Amyotrophic lateral sclerosis (ALS) WP2447,0.18793381793348127,2.625886101154918,4.389602966947666,"['BAD', 'NEFH']",0.7528575489944465,0,0,2
62,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.18793381793348127,2.625886101154918,4.389602966947666,"['LDHA', 'PKM']",0.7528575489944465,0,0,2
63,Tryptophan metabolism WP465,0.19669870766039005,2.543672839506173,4.13622093289651,"['DHCR24', 'HSD17B10']",0.7528575489944465,0,0,2
64,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.19680789165663656,5.082204433497537,8.261261518656779,['SOCS3'],0.7528575489944465,0,0,1
65,Melanoma WP4685,0.19939413048993015,2.0030027592923227,3.2297855803455855,"['GADD45B', 'BAD', 'KRAS']",0.7528575489944465,0,0,3
66,7q11.23 copy number variation syndrome WP4932,0.20529348132847,1.7526614904346434,2.775014714886189,"['CLTC', 'HMGA1', 'GAPDH', 'ATP5F1D']",0.7528575489944465,0,0,4
67,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.20551263541650094,2.4664421997755333,3.902522647550912,"['IFITM3', 'IFITM2']",0.7528575489944465,0,0,2
68,Oxysterols derived from cholesterol WP4545,0.20551263541650094,2.4664421997755333,3.902522647550912,"['THEM5', 'ACOT4']",0.7528575489944465,0,0,2
69,MECP2 and Associated Rett Syndrome WP3584,0.21185043795999361,1.9391796322489392,3.009363877137968,"['GAMT', 'RPS6', 'TET3']",0.7528575489944465,0,0,3
70,Regulatory circuits of the STAT3 signaling pathway WP4538,0.21185043795999361,1.9391796322489392,3.009363877137968,"['IL15RA', 'SOCS3', 'MAPK4']",0.7528575489944465,0,0,3
71,IL-2 signaling pathway WP49,0.21436819541597613,2.393754538852578,3.6865261011943224,"['SOCS3', 'RPS6']",0.7528575489944465,0,0,2
72,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.21436819541597613,2.393754538852578,3.6865261011943224,"['FSHR', 'KRAS']",0.7528575489944465,0,0,2
73,Trans-sulfuration pathway WP2333,0.21613614380949445,4.517241379310345,6.919721636247068,['AHCY'],0.7528575489944465,0,0,1
74,Valproic acid pathway WP3871,0.21613614380949445,4.517241379310345,6.919721636247068,['HSD17B10'],0.7528575489944465,0,0,1
75,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.21613614380949445,4.517241379310345,6.919721636247068,['AHCY'],0.7528575489944465,0,0,1
76,Nanoparticle triggered regulated necrosis WP2513,0.21613614380949445,4.517241379310345,6.919721636247068,['FTL'],0.7528575489944465,0,0,1
77,G13 Signaling Pathway WP524,0.22325830820871445,2.3252204585537917,3.486495651104582,"['CFL2', 'ARHGDIG']",0.7528575489944465,0,0,2
78,Thermogenesis WP4321,0.22553956209902248,1.6799774884244456,2.5019227599123175,"['CREB3', 'RPS6', 'ZNF516', 'KRAS']",0.7528575489944465,0,0,4
79,Apoptosis WP254,0.23083449747530912,1.8506975697569756,2.7132231049484674,"['IRF3', 'DIABLO', 'BAD']",0.7528575489944465,0,0,3
80,Biomarkers for urea cycle disorders WP4583,0.2350003903404396,4.065270935960591,5.8871957028291995,['GAMT'],0.7528575489944465,0,0,1
81,Cells and molecules involved in local acute inflammatory response  WP4493,0.2350003903404396,4.065270935960591,5.8871957028291995,['ICAM1'],0.7528575489944465,0,0,1
82,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.2350003903404396,4.065270935960591,5.8871957028291995,['HMGCS1'],0.7528575489944465,0,0,1
83,Non-small cell lung cancer WP4255,0.23723174429230887,1.822964385990838,2.6227312955550603,"['GADD45B', 'BAD', 'KRAS']",0.7528575489944465,0,0,3
84,Aryl Hydrocarbon Receptor Netpath WP2586,0.25006982621400853,2.1412605588044182,2.9678194573924896,"['AIP', 'KRAS']",0.7528575489944465,0,0,2
85,Platelet-mediated interactions with vascular and circulating cells WP4462,0.2534117435575187,3.695476936856247,5.072927784202227,['ICAM1'],0.7528575489944465,0,0,1
86,Splicing factor NOVA regulated synaptic proteins WP4148,0.2590334902440118,2.086229819563153,2.8180749002412466,"['APLP2', 'MAPK4']",0.7528575489944465,0,0,2
87,Eukaryotic Transcription Initiation WP405,0.268000818249928,2.0339506172839505,2.678235483505279,"['GTF2A2', 'POLR3H']",0.7528575489944465,0,0,2
88,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.2713810502798885,3.3873152709359604,4.417842789442661,['CCK'],0.7528575489944465,0,0,1
89,Apoptosis Modulation and Signaling WP1772,0.27616366959718,1.6725213617252137,2.1521362354104934,"['ENDOG', 'DIABLO', 'BAD']",0.7528575489944465,0,0,3
90,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.2769664619285321,1.9842216199939777,2.54746049948361,"['ATG101', 'FTL']",0.7528575489944465,0,0,2
91,Ebola Virus Pathway on Host WP4217,0.2780819291312597,1.5220426242434082,1.9479702705883237,"['SOCS3', 'IRF3', 'CLTC', 'HLA-B']",0.7528575489944465,0,0,4
92,Focal Adhesion WP306,0.2785024325980934,1.3811234625301154,1.7655294634677234,"['SHC3', 'LAMB3', 'LAMC3', 'BAD', 'VEGFB', 'RAC3']",0.7528575489944465,0,0,6
93,Alzheimer's disease WP2059,0.2827210175915172,1.6498193738292748,2.084208023279534,"['BAD', 'GAPDH', 'HSD17B10']",0.7528575489944465,0,0,3
94,Cysteine and methionine catabolism WP4504,0.2889188981884611,3.1265630920803336,3.8819696850973338,['AHCY'],0.7528575489944465,0,0,1
95,Fatty acid transporters WP5061,0.2889188981884611,3.1265630920803336,3.8819696850973338,['DBI'],0.7528575489944465,0,0,1
96,Galanin receptor pathway WP4970,0.2889188981884611,3.1265630920803336,3.8819696850973338,['POMC'],0.7528575489944465,0,0,1
97,Kennedy pathway from sphingolipids WP3933,0.2889188981884611,3.1265630920803336,3.8819696850973338,['CHKA'],0.7528575489944465,0,0,1
98,Leptin Insulin Overlap WP3935,0.2889188981884611,3.1265630920803336,3.8819696850973338,['SOCS3'],0.7528575489944465,0,0,1
99,miR-509-3p alteration of YAP1/ECM axis WP3967,0.2889188981884611,3.1265630920803336,3.8819696850973338,['SPARC'],0.7528575489944465,0,0,1
100,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.2889188981884611,3.1265630920803336,3.8819696850973338,['IRF3'],0.7528575489944465,0,0,1
101,Amino Acid metabolism WP3925,0.29587368572743133,1.6062076602397082,1.9560760742928924,"['ACLY', 'LDHA', 'PKM']",0.7528575489944465,0,0,3
102,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.30603562205193763,2.9030612244897958,3.437380592828608,['ACLY'],0.7528575489944465,0,0,1
103,Blood Clotting Cascade WP272,0.30603562205193763,2.9030612244897958,3.437380592828608,['F8A1'],0.7528575489944465,0,0,1
104,EGF/EGFR signaling pathway WP437,0.3172655721587795,1.3569651741293531,1.5578178518057126,"['MAP4K1', 'KRAS', 'FOXO4', 'MAPK4', 'ARF6']",0.7528575489944465,0,0,5
105,Insulin Signaling WP481,0.3172655721587795,1.3569651741293531,1.5578178518057126,"['MAP4K1', 'SOCS3', 'SHC3', 'MAPK4', 'ARF6']",0.7528575489944465,0,0,5
106,Cytosolic DNA-sensing pathway WP4655,0.32159950063840076,1.7680085882984433,2.005714327514767,"['IRF3', 'POLR3H']",0.7528575489944465,0,0,2
107,IL-4 signaling pathway WP395,0.32159950063840076,1.7680085882984433,2.005714327514767,"['SOCS3', 'BAD']",0.7528575489944465,0,0,2
108,Serotonin and anxiety WP3947,0.32274130964392916,2.70935960591133,3.0640260914880306,['POMC'],0.7528575489944465,0,0,1
109,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.32274130964392916,2.70935960591133,3.0640260914880306,['HMGCS1'],0.7528575489944465,0,0,1
110,MAPK pathway in congenital thyroid cancer WP4928,0.32274130964392916,2.70935960591133,3.0640260914880306,['KRAS'],0.7528575489944465,0,0,1
111,SARS coronavirus and innate immunity WP4912,0.32274130964392916,2.70935960591133,3.0640260914880306,['IRF3'],0.7528575489944465,0,0,1
112,Metapathway biotransformation Phase I and II WP702,0.32685101941730593,1.403183023872679,1.5691105530427474,"['CHST8', 'GSTO1', 'GSTP1', 'CYP51A1']",0.7528575489944465,0,0,4
113,PI3K-Akt signaling pathway WP4172,0.3283872509199764,1.2389910136558124,1.3796929691377635,"['CREB3', 'LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'EPOR']",0.7528575489944465,0,0,8
114,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.3390458077003806,2.5398706896551726,2.747175074454948,['EIF3G'],0.7528575489944465,0,0,1
115,PPAR-alpha pathway WP2878,0.3390458077003806,2.5398706896551726,2.747175074454948,['DBI'],0.7528575489944465,0,0,1
116,Translation Factors WP107,0.34806891693910635,1.6594608213655833,1.7513199127609542,"['EEF1G', 'EIF3G']",0.7528575489944465,0,0,2
117,Interferon type I signaling pathways WP585,0.34806891693910635,1.6594608213655833,1.7513199127609542,"['SOCS3', 'RPS6']",0.7528575489944465,0,0,2
118,Senescence and Autophagy in Cancer WP615,0.34867863128079973,1.45252828854314,1.530390498462097,"['SPARC', 'HMGA1', 'ING1']",0.7528575489944465,0,0,3
119,ErbB signaling pathway WP673,0.34867863128079973,1.45252828854314,1.530390498462097,"['SHC3', 'BAD', 'KRAS']",0.7528575489944465,0,0,3
120,15q13.3 copy number variation syndrome WP4942,0.3549587277521585,2.390321645899739,2.475784623072002,['TRPM1'],0.7528575489944465,0,0,1
121,IL1 and megakaryocytes in obesity WP2865,0.3549587277521585,2.390321645899739,2.475784623072002,['ICAM1'],0.7528575489944465,0,0,1
122,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3549587277521585,2.390321645899739,2.475784623072002,['KRAS'],0.7528575489944465,0,0,1
123,TNF-alpha signaling pathway WP231,0.35526833075902786,1.4353523587652883,1.4854201959201483,"['DIABLO', 'BAD', 'KRAS']",0.7528575489944465,0,0,3
124,TGF-beta Signaling Pathway WP366,0.3596755779899778,1.333685880486515,1.3637642661969744,"['MAP4K1', 'PARD6A', 'CITED1', 'MAPK4']",0.7528575489944465,0,0,4
125,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.370489451379396,2.2573891625615765,2.241430111857531,['KRAS'],0.7528575489944465,0,0,1
126,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.370489451379396,2.2573891625615765,2.241430111857531,['IRF3'],0.7528575489944465,0,0,1
127,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.370489451379396,2.2573891625615765,2.241430111857531,['BAD'],0.7528575489944465,0,0,1
128,Imatinib and Chronic Myeloid Leukemia WP3640,0.370489451379396,2.2573891625615765,2.241430111857531,['SPRED2'],0.7528575489944465,0,0,1
129,Hepatitis B infection WP4666,0.3706205286844221,1.3120147282478187,1.3022750834255292,"['CREB3', 'IRF3', 'BAD', 'KRAS']",0.7528575489944465,0,0,4
130,Prader-Willi and Angelman Syndrome WP3998,0.3741846233477024,1.5634377967711302,1.5368686692754319,"['POMC', 'GNRH1']",0.7528575489944465,0,0,2
131,Small cell lung cancer WP4658,0.37497916105273416,1.3861667416741674,1.3596699219413677,"['LAMB3', 'GADD45B', 'LAMC3']",0.7528575489944465,0,0,3
132,"GPCRs, Class A Rhodopsin-like WP455",0.3760888251427128,1.301439205955335,1.2727163469071785,"['FSHR', 'APLNR', 'OPRL1', 'HCRTR1']",0.7528575489944465,0,0,4
133,Endochondral Ossification with Skeletal Dysplasias WP4808,0.3827967891701773,1.5338457954810156,1.4728769699789994,"['HMGCS1', 'ADAMTS1']",0.7528575489944465,0,0,2
134,Endochondral Ossification WP474,0.3827967891701773,1.5338457954810156,1.4728769699789994,"['HMGCS1', 'ADAMTS1']",0.7528575489944465,0,0,2
135,Urea cycle and metabolism of amino groups WP497,0.38564713614784557,2.138449572206378,2.037584214948414,['GAMT'],0.7528575489944465,0,0,1
136,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.38564713614784557,2.138449572206378,2.037584214948414,['H3F3A'],0.7528575489944465,0,0,1
137,Hippo-Yap signaling pathway WP4537,0.38564713614784557,2.138449572206378,2.037584214948414,['MAP4K1'],0.7528575489944465,0,0,1
138,Methionine De Novo and Salvage Pathway WP3580,0.38564713614784557,2.138449572206378,2.037584214948414,['AHCY'],0.7528575489944465,0,0,1
139,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.38564713614784557,2.138449572206378,2.037584214948414,['ICAM1'],0.7528575489944465,0,0,1
140,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.38564713614784557,2.138449572206378,2.037584214948414,['LDHA'],0.7528575489944465,0,0,1
141,"Relationship between inflammation, COX-2 and EGFR WP4483",0.38564713614784557,2.138449572206378,2.037584214948414,['KRAS'],0.7528575489944465,0,0,1
142,Integrin-mediated Cell Adhesion WP185,0.3880545845332343,1.3551980198019802,1.2828430047973889,"['SHC3', 'RAC3', 'MAPK4']",0.7528575489944465,0,0,3
143,Kit receptor signaling pathway WP304,0.39135782008398456,1.505349794238683,1.4122183134050468,"['BAD', 'RPS6']",0.7528575489944465,0,0,2
144,MET in type 1 papillary renal cell carcinoma WP4205,0.3998651939695042,1.4778900112233446,1.3546750751757635,"['BAD', 'KRAS']",0.7528575489944465,0,0,2
145,IL-7 signaling pathway WP205,0.40044072070993325,2.0314039408866993,1.8591196313835174,['BAD'],0.7528575489944465,0,0,1
146,Kallmann's Syndrome WP5074,0.40044072070993325,2.0314039408866993,1.8591196313835174,['GNRH1'],0.7528575489944465,0,0,1
147,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.40044072070993325,2.0314039408866993,1.8591196313835174,['HMGA1'],0.7528575489944465,0,0,1
148,Spinal Cord Injury WP2431,0.4010632952964643,1.325575764098149,1.211093765981194,"['BCAN', 'OMG', 'ICAM1']",0.7528575489944465,0,0,3
149,"GPCRs, Other WP117",0.40831653903000265,1.451410934744268,1.300047024905992,"['FSHR', 'CELSR2']",0.7528575489944465,0,0,2
150,Myometrial relaxation and contraction pathways WP289,0.41419556727591517,1.2318971351229415,1.0858151165335537,"['CNN1', 'CREB3', 'GSTO1', 'IGFBP6']",0.7528575489944465,0,0,4
151,Statin inhibition of cholesterol production WP430,0.41487892989024816,1.9345531315974667,1.7019589774030806,['APOC1'],0.7528575489944465,0,0,1
152,Fatty Acid Biosynthesis WP357,0.41487892989024816,1.9345531315974667,1.7019589774030806,['ACLY'],0.7528575489944465,0,0,1
153,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.41487892989024816,1.9345531315974667,1.7019589774030806,['GSTP1'],0.7528575489944465,0,0,1
154,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.41670962789246463,1.4258609486679663,1.2481496757892376,"['IFI27L2', 'KRAS']",0.7528575489944465,0,0,2
155,Regulation of Actin Cytoskeleton WP51,0.4249997950156361,1.2133624680567385,1.0382337283565999,"['CFL2', 'RAC3', 'KRAS', 'MAPK4']",0.7528575489944465,0,0,4
156,p53 transcriptional gene network WP4963,0.4250423721651805,1.4011919965942954,1.198812814395079,"['MGMT', 'ICAM1']",0.7528575489944465,0,0,2
157,DNA damage response (only ATM dependent) WP710,0.4268344692890217,1.2700340346534653,1.081254906543785,"['BAD', 'RAC3', 'KRAS']",0.7528575489944465,0,0,3
158,TLR4 Signaling and Tolerance WP3851,0.42897028019923483,1.8465069413345276,1.5628237210337572,['IRF3'],0.7528575489944465,0,0,1
159,EPO Receptor Signaling WP581,0.42897028019923483,1.8465069413345276,1.5628237210337572,['EPOR'],0.7528575489944465,0,0,1
160,G1 to S cell cycle control WP45,0.4333128171505005,1.377359280184139,1.1518791893386378,"['CREB3', 'CCNB1']",0.7528575489944465,0,0,2
161,Signal Transduction of S1P Receptor WP26,0.442723084354171,1.7661169415292355,1.439051151203092,['MAPK4'],0.7528575489944465,0,0,1
162,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.442723084354171,1.7661169415292355,1.439051151203092,['IRF3'],0.7528575489944465,0,0,1
163,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.442723084354171,1.7661169415292355,1.439051151203092,['H3F3A'],0.7528575489944465,0,0,1
164,Gastric Cancer Network 1 WP2361,0.442723084354171,1.7661169415292355,1.439051151203092,['H3F3A'],0.7528575489944465,0,0,1
165,miRNAs involvement in the immune response in sepsis WP4329,0.442723084354171,1.7661169415292355,1.439051151203092,['ICAM1'],0.7528575489944465,0,0,1
166,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.442723084354171,1.7661169415292355,1.439051151203092,['OMG'],0.7528575489944465,0,0,1
167,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4496596269727747,1.3320380489779398,1.0646505479374377,"['BAD', 'KRAS']",0.7528575489944465,0,0,2
168,MTHFR deficiency WP4288,0.456145456367877,1.6924261083743843,1.328458935735663,['CHKA'],0.7528575489944465,0,0,1
169,Ovarian infertility WP34,0.456145456367877,1.6924261083743843,1.328458935735663,['FSHR'],0.7528575489944465,0,0,1
170,Photodynamic therapy-induced unfolded protein response WP3613,0.456145456367877,1.6924261083743843,1.328458935735663,['DNAJB9'],0.7528575489944465,0,0,1
171,DNA damage response WP707,0.4577327043946622,1.31047391477499,1.0240958930484223,"['CCNB1', 'GADD45B']",0.7528575489944465,0,0,2
172,Male infertility WP4673,0.4584795843639276,1.20679345162239,0.9411052203699304,"['PIWIL1', 'DND1', 'HMGA1']",0.7528575489944465,0,0,3
173,Gastrin signaling pathway WP4659,0.464721044727643,1.194889341875364,0.9156651595705848,"['BAD', 'RPS6', 'KRAS']",0.7528575489944465,0,0,3
174,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.465736898018998,1.289594356261023,0.9854234107312461,"['PSMC3', 'STUB1']",0.7528575489944465,0,0,2
175,Toll-like Receptor Signaling related to MyD88 WP3858,0.4692453163538414,1.6246305418719211,1.2292435321830388,['IRF3'],0.7528575489944465,0,0,1
176,White fat cell differentiation WP4149,0.4692453163538414,1.6246305418719211,1.2292435321830388,['IRF3'],0.7528575489944465,0,0,1
177,Acute viral myocarditis WP4298,0.4736708465234206,1.2693672839506174,0.9485253288111097,"['ENDOG', 'RAC3']",0.7528575489944465,0,0,2
178,miRNA regulation of DNA damage response WP1530,0.4736708465234206,1.2693672839506174,0.9485253288111097,"['CCNB1', 'GADD45B']",0.7528575489944465,0,0,2
179,Ethanol effects on histone modifications WP3996,0.4820303948980659,1.5620500189465707,1.139903044311275,['AHCY'],0.7528575489944465,0,0,1
180,Lipid Metabolism Pathway WP3965,0.4820303948980659,1.5620500189465707,1.139903044311275,['ACLY'],0.7528575489944465,0,0,1
181,Nanoparticle-mediated activation of receptor signaling WP2643,0.4820303948980659,1.5620500189465707,1.139903044311275,['KRAS'],0.7528575489944465,0,0,1
182,Adipogenesis WP236,0.48325159245190474,1.1605374823196606,0.8439635908446587,"['SOCS3', 'GADD45B', 'HMGA1']",0.7528575489944465,0,0,3
183,16p11.2 proximal deletion syndrome WP4949,0.4893230834624364,1.2307519640852975,0.8796581885405037,"['TMEM219', 'CCT7']",0.7528575489944465,0,0,2
184,NRF2 pathway WP2884,0.48936069118627873,1.1495189613300953,0.8215099924548569,"['PRDX1', 'GSTP1', 'FTL']",0.7528575489944465,0,0,3
185,Aryl Hydrocarbon Receptor Pathway WP2873,0.4945082378596648,1.5041050903119868,1.0591779732127737,['AIP'],0.7528575489944465,0,0,1
186,Endothelin Pathways WP2197,0.4945082378596648,1.5041050903119868,1.0591779732127737,['CNN1'],0.7528575489944465,0,0,1
187,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4945082378596648,1.5041050903119868,1.0591779732127737,['KRAS'],0.7528575489944465,0,0,1
188,Glycerophospholipid Biosynthetic Pathway WP2533,0.4945082378596648,1.5041050903119868,1.0591779732127737,['PTPMT1'],0.7528575489944465,0,0,1
189,One-carbon metabolism WP241,0.4945082378596648,1.5041050903119868,1.0591779732127737,['AHCY'],0.7528575489944465,0,0,1
190,Autophagy WP4923,0.5066862105767875,1.4502990851513018,0.9860052395604014,['ATG101'],0.7528575489944465,0,0,1
191,Trans-sulfuration and one-carbon metabolism WP2525,0.5066862105767875,1.4502990851513018,0.9860052395604014,['AHCY'],0.7528575489944465,0,0,1
192,Heart Development WP1591,0.5066862105767875,1.4502990851513018,0.9860052395604014,['VEGFB'],0.7528575489944465,0,0,1
193,Head and Neck Squamous Cell Carcinoma WP4674,0.5122463780493107,1.1770263016639828,0.7873712296174874,"['RPS6', 'KRAS']",0.7528575489944465,0,0,2
194,Base Excision Repair WP4752,0.5185715022397734,1.400203838967216,0.9194821586403481,['TDG'],0.7528575489944465,0,0,1
195,Tumor suppressor activity of SMARCB1 WP4204,0.5185715022397734,1.400203838967216,0.9194821586403481,['H3F3A'],0.7528575489944465,0,0,1
196,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5185715022397734,1.400203838967216,0.9194821586403481,['IRF3'],0.7528575489944465,0,0,1
197,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5185715022397734,1.400203838967216,0.9194821586403481,['COPS6'],0.7528575489944465,0,0,1
198,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5185715022397734,1.400203838967216,0.9194821586403481,['FOXO4'],0.7528575489944465,0,0,1
199,Complement system WP2806,0.5197358553476681,1.1601410934744267,0.75923643411189,"['FCGR3A', 'ICAM1']",0.7528575489944465,0,0,2
200,Prolactin Signaling Pathway WP2037,0.527148268517388,1.1437315249521822,0.7323009014197409,"['SOCS3', 'RPS6']",0.7528575489944465,0,0,2
201,Zinc homeostasis WP3529,0.5301711301923425,1.353448275862069,0.8588379626844738,['MT3'],0.7528575489944465,0,0,1
202,Fluoropyrimidine Activity WP1601,0.5301711301923425,1.353448275862069,0.8588379626844738,['TDG'],0.7528575489944465,0,0,1
203,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5301711301923425,1.353448275862069,0.8588379626844738,['IRF3'],0.7528575489944465,0,0,1
204,Joubert Syndrome WP4656,0.5344829847900194,1.1277777777777778,0.7065024596104778,"['PDE6G', 'ARL2']",0.7528575489944465,0,0,2
205,Nuclear Receptors Meta-Pathway WP2882,0.5357389233904165,1.0233030868207633,0.6386519701636397,"['GADD45B', 'PRDX1', 'GSTP1', 'AIP', 'DBI', 'FTL']",0.7528575489944465,0,0,6
206,Fragile X Syndrome  WP4549,0.5368955482071569,1.0683298593017196,0.66444958630786,"['DUSP3', 'CLTC', 'KRAS']",0.7528575489944465,0,0,3
207,T-cell receptor (TCR) signaling pathway WP69,0.541739445922009,1.1122611195670555,0.6817828321658866,"['MAP4K1', 'IL15RA']",0.7528575489944465,0,0,2
208,Alpha 6 Beta 4 signaling pathway WP244,0.5525406286190909,1.2687038177339902,0.7526310246431325,['LAMB3'],0.7528575489944465,0,0,1
209,BDNF-TrkB Signaling WP3676,0.5525406286190909,1.2687038177339902,0.7526310246431325,['KRAS'],0.7528575489944465,0,0,1
210,CAMKK2  Pathway WP4874,0.5525406286190909,1.2687038177339902,0.7526310246431325,['ICAM1'],0.7528575489944465,0,0,1
211,MAPK Cascade WP422,0.5525406286190909,1.2687038177339902,0.7526310246431325,['KRAS'],0.7528575489944465,0,0,1
212,Nuclear receptors WP170,0.5525406286190909,1.2687038177339902,0.7526310246431325,['NR2F6'],0.7528575489944465,0,0,1
213,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5633237103673725,1.2301836094939542,0.7060034093857568,['MAP4K1'],0.7528575489944465,0,0,1
214,Microglia Pathogen Phagocytosis Pathway WP3937,0.5633237103673725,1.2301836094939542,0.7060034093857568,['RAC3'],0.7528575489944465,0,0,1
215,Parkinson's disease pathway WP2371,0.5633237103673725,1.2301836094939542,0.7060034093857568,['PINK1'],0.7528575489944465,0,0,1
216,Pre-implantation embryo WP3527,0.5633237103673725,1.2301836094939542,0.7060034093857568,['HMGA1'],0.7528575489944465,0,0,1
217,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5652944226013664,1.0231300440968467,0.5836021572587713,"['MAP4K1', 'SHC3', 'MAPK4']",0.7528575489944465,0,0,3
218,Ciliary landscape WP4352,0.5717286730372138,0.9895643732556728,0.5532562856157989,"['MYL6', 'COPS6', 'SSNA1', 'H3F3A', 'RANBP10']",0.7538270202831446,0,0,5
219,Bladder cancer WP2828,0.5738475586930513,1.1939292958562735,0.6630981766982513,['KRAS'],0.7538270202831446,0,0,1
220,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5738475586930513,1.1939292958562735,0.6630981766982513,['CREB3'],0.7538270202831446,0,0,1
221,Glioblastoma signaling pathways WP2261,0.5836122338780537,1.027410532895765,0.5532795788268581,"['KRAS', 'FOXO4']",0.7631852289174549,0,0,2
222,Oxidation by Cytochrome P450 WP43,0.5941422746613109,1.1274630541871922,0.5869983830855484,['CYP51A1'],0.7676494598836586,0,0,1
223,Oxidative Damage WP3941,0.5941422746613109,1.1274630541871922,0.5869983830855484,['BAD'],0.7676494598836586,0,0,1
224,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5979339615061381,0.9736633663366336,0.500730692080442,"['ATP1A3', 'GAPDH', 'SLC25A4']",0.7676494598836586,0,0,3
225,Androgen receptor signaling pathway WP138,0.6034670829689124,0.9896416741945198,0.49983216825805504,"['PRDX1', 'STUB1']",0.7676494598836586,0,0,2
226,ATM Signaling Pathway WP2516,0.6039251341053958,1.0969245107176142,0.5531845580328993,['CCNB1'],0.7676494598836586,0,0,1
227,Ferroptosis WP4313,0.6039251341053958,1.0969245107176142,0.5531845580328993,['FTL'],0.7676494598836586,0,0,1
228,Circadian rhythm related genes WP3594,0.6056196430916061,0.95431323894322,0.4785910874316106,"['AHCY', 'OPRL1', 'NR2F6', 'HCRTR1']",0.7676494598836586,0,0,4
229,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.613472750355179,1.0679932590095929,0.5218422601488176,['RPS6'],0.7708418471854206,0,0,1
230,PDGF Pathway WP2526,0.613472750355179,1.0679932590095929,0.5218422601488176,['ARFIP2'],0.7708418471854206,0,0,1
231,Nephrotic syndrome WP4758,0.6227907666967599,1.0405456612353163,0.49274484615381975,['MYO1E'],0.77580401541105,0,0,1
232,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6227907666967599,1.0405456612353163,0.49274484615381975,['BAD'],0.77580401541105,0,0,1
233,Breast cancer pathway WP4262,0.6289332985784085,0.928727987302547,0.43067909595609444,"['SHC3', 'GADD45B', 'KRAS']",0.7800932330006869,0,0,3
234,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6318846910717554,1.0144704433497538,0.4656909854942934,['MAP4K1'],0.7804045970928944,0,0,1
235,Integrated Cancer Pathway WP1971,0.640759899921731,0.9896671873122672,0.44050132362081923,['BAD'],0.7816541294623864,0,0,1
236,Notch Signaling WP268,0.640759899921731,0.9896671873122672,0.44050132362081923,['DTX3'],0.7816541294623864,0,0,1
237,B Cell Receptor Signaling Pathway WP23,0.6410104798705384,0.9218294051627385,0.40994626891337704,"['MAP4K1', 'MAPK4']",0.7816541294623864,0,0,2
238,IL-3 signaling pathway WP286,0.6494216407729759,0.9660450387051372,0.41701565235739146,['BAD'],0.7828545374687156,0,0,1
239,Netrin-UNC5B signaling pathway WP4747,0.6494216407729759,0.9660450387051372,0.41701565235739146,['ICAM1'],0.7828545374687156,0,0,1
240,Complement and Coagulation Cascades WP558,0.6578750356859682,0.9435215946843853,0.3950904977479954,['CLTC'],0.7828545374687156,0,0,1
241,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6578750356859682,0.9435215946843853,0.3950904977479954,['KRAS'],0.7828545374687156,0,0,1
242,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6578750356859682,0.9435215946843853,0.3950904977479954,['IRF3'],0.7828545374687156,0,0,1
243,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.65824793288892,0.8877285538772856,0.37122466377224356,"['SHC3', 'BAD', 'RPS6']",0.7828545374687156,0,0,3
244,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6741766656193459,0.9014778325123153,0.3554194333371454,['RPS6'],0.7920205543251665,0,0,1
245,Histone Modifications WP2369,0.6741766656193459,0.9014778325123153,0.3554194333371454,['H3F3A'],0.7920205543251665,0,0,1
246,One-carbon metabolism and related pathways WP3940,0.6741766656193459,0.9014778325123153,0.3554194333371454,['CHKA'],0.7920205543251665,0,0,1
247,22q11.2 copy number variation syndrome WP4657,0.6812111805610591,0.8535412605588044,0.3276599091314851,"['THAP7', 'DGCR6L']",0.7941206086959498,0,0,2
248,Exercise-induced Circadian Regulation WP410,0.6820345432977364,0.8818269436710217,0.337453101352632,['GSTP1'],0.7941206086959498,0,0,1
249,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6897033660300463,0.8630122628655277,0.32060359980360736,['KRAS'],0.7941206086959498,0,0,1
250,Phosphoinositides metabolism WP4971,0.6897033660300463,0.8630122628655277,0.32060359980360736,['PIP4P1'],0.7941206086959498,0,0,1
251,Rett syndrome causing genes WP4312,0.6897033660300463,0.8630122628655277,0.32060359980360736,['IMPDH2'],0.7941206086959498,0,0,1
252,Copper homeostasis WP3286,0.6971876713059736,0.8449815270935961,0.30478538491592944,['MT3'],0.7983097312162234,0,0,1
253,Allograft Rejection WP2328,0.7044918881862041,0.8276867397205188,0.28992083820272,['HLA-B'],0.7983097312162234,0,0,1
254,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.711620339441127,0.8110837438423645,0.2759394014330306,['SOCS3'],0.7983097312162234,0,0,1
255,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.711620339441127,0.8110837438423645,0.2759394014330306,['IRF3'],0.7983097312162234,0,0,1
256,Phosphodiesterases in neuronal function WP4222,0.711620339441127,0.8110837438423645,0.2759394014330306,['PDE6G'],0.7983097312162234,0,0,1
257,RANKL/RANK signaling pathway WP2018,0.711620339441127,0.8110837438423645,0.2759394014330306,['ICAM1'],0.7983097312162234,0,0,1
258,Regulation of toll-like receptor signaling pathway WP1449,0.7126778915355905,0.8025424764698692,0.27184178272456155,"['CUEDC2', 'IRF3']",0.7983097312162234,0,0,2
259,Cardiac Hypertrophic Response WP2795,0.7185772444975488,0.795131845841785,0.2627768193244715,['MAP4K1'],0.7987262448453524,0,0,1
260,Genotoxicity pathway WP4286,0.7185772444975488,0.795131845841785,0.2627768193244715,['PHLDA3'],0.7987262448453524,0,0,1
261,Modulators of TCR signaling and T cell activation WP5072,0.7253667217404609,0.7797934823796893,0.2503744763097717,['MAP4K1'],0.8001182541335619,0,0,1
262,PPAR signaling pathway WP3942,0.7253667217404609,0.7797934823796893,0.2503744763097717,['DBI'],0.8001182541335619,0,0,1
263,AGE/RAGE pathway WP2324,0.7569400576504817,0.711174487943998,0.19804162214257565,['FOXO4'],0.8280886630940397,0,0,1
264,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7569400576504817,0.711174487943998,0.19804162214257565,['NEFH'],0.8280886630940397,0,0,1
265,Cell cycle WP179,0.7593200543941887,0.7297964631297965,0.20093625514429553,"['CCNB1', 'GADD45B']",0.8280886630940397,0,0,2
266,Glucocorticoid Receptor Pathway WP2880,0.7741178507643428,0.6754926108374384,0.17294715335589664,['GADD45B'],0.8410528528981018,0,0,1
267,AMP-activated protein kinase (AMPK) signaling WP1403,0.7795702802570904,0.6643785835419527,0.1654385280919203,['CCNB1'],0.8412160411226133,0,0,1
268,Vitamin D Receptor Pathway WP2877,0.7800896159891362,0.6981268624946786,0.17337734442902195,"['COLEC11', 'DND1']",0.8412160411226133,0,0,2
269,DNA Repair Pathways Full Network WP4946,0.7840504252257298,0.6921177587844255,0.1683797530104296,"['MGMT', 'TDG']",0.8423441371384235,0,0,2
270,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7900843979993976,0.6432090077410274,0.15155001602634446,['RPS6'],0.8456829297104663,0,0,1
271,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7951523191276881,0.633120381773399,0.14512485822454077,['MYO1E'],0.847966864309601,0,0,1
272,Chemokine signaling pathway WP3929,0.806523502228916,0.6581150255947004,0.1415093675246787,"['SHC3', 'KRAS']",0.8545457370607308,0,0,2
273,MAPK Signaling Pathway WP382,0.8072352464276107,0.715386811304596,0.15319303610975546,"['MAP4K1', 'DUSP3', 'RAC3', 'KRAS']",0.8545457370607308,0,0,4
274,Ectoderm Differentiation WP2858,0.8135396947123862,0.6475061728395062,0.13361973548409645,"['ARHGDIG', 'CELSR2']",0.8580765393134292,0,0,2
275,Toll-like Receptor Signaling Pathway WP75,0.8273694687000301,0.5704572261153126,0.1081038839215292,['IRF3'],0.8694900961974863,0,0,1
276,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.845317802361235,0.5991769547325103,0.1006872682306527,"['SPARC', 'KRAS']",0.8839406449799775,0,0,2
277,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8472372271953418,0.5327651024112005,0.08831889202408116,['MAPK4'],0.8839406449799775,0,0,1
278,Corticotropin-releasing hormone signaling pathway WP2355,0.8580452687201423,0.5124399825403754,0.07845375174344293,['POMC'],0.8862906241596382,0,0,1
279,Integrated breast cancer pathway WP1984,0.8645523972626281,0.569396626673622,0.08287190151599552,"['BAD', 'KRAS']",0.8862906241596382,0,0,2
280,Neural Crest Differentiation WP2064,0.8648233772076745,0.4997263273125342,0.07257524507013531,['PRTG'],0.8862906241596382,0,0,1
281,Pyrimidine metabolism WP4022,0.8648233772076745,0.4997263273125342,0.07257524507013531,['POLR3H'],0.8862906241596382,0,0,1
282,Retinoblastoma gene in cancer WP2446,0.8648233772076745,0.4997263273125342,0.07257524507013531,['CCNB1'],0.8862906241596382,0,0,1
283,G Protein Signaling Pathways WP35,0.8803893667277611,0.47052927024859664,0.05994119764312303,['KRAS'],0.8990548656689857,0,0,1
284,Wnt signaling pathway and pluripotency WP399,0.8915441626185066,0.44950738916256155,0.051603585589697944,['PPM1J'],0.9072403626646071,0,0,1
285,ESC Pluripotency Pathways WP3931,0.9150982925215994,0.4043103448275862,0.03587194853707361,['MAPK4'],0.9255624434559218,0,0,1
286,Hippo-Merlin Signaling Dysregulation WP4541,0.9191571670306213,0.39633439582729646,0.033410256995162535,['KRAS'],0.9255624434559218,0,0,1
287,Osteoblast differentiation WP4787,0.9191571670306213,0.39633439582729646,0.033410256995162535,['MAPK4'],0.9255624434559218,0,0,1
288,mRNA Processing WP411,0.9539956806785765,0.3229556650246305,0.015209963642513908,['SRSF3'],0.9573081656809328,0,0,1
289,Ciliopathies WP4803,0.9851364411467141,0.23541612652320457,0.003525386739120971,['CCDC28B'],0.9851364411467141,0,0,1
